MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bph.15741

Медицинская библиотека · British journal of pharmacology · 2021

L6H21 protects against cognitive impairment and brain pathologies via toll-like receptor 4-myeloid differentiation factor 2 signalling in prediabetic rats.

Oo Thura Tun, Sumneang Natticha, Ongnok Benjamin, Arunsak Busarin, Chunchai Titikorn, Kerdphoo Sasiwan, Apaijai Nattayaporn, Pratchayasakul Wasana, Liang Guang, Chattipakorn Nipon, Chattipakorn Siriporn C

СтатьяПоддержка исследования: вне правительства СШАОтозванная публикацияПеревод в очереди
Источник пометил публикацию как отозванную.

Аннотация

BACKGROUND AND PURPOSE: Chronic high-fat diet (HFD) intake instigates prediabetes and brain pathologies, which include cognitive decline and neuroinflammation. The myeloid differentiation factor 2 (MD-2)/toll-like receptor 4 (TLR4) complex plays a pivotal role in neuroinflammation. The MD-2 inhibitor (L6H21) reduces systemic inflammation and metabolic disturbances in HFD-induced prediabetes. However, the potential role of L6H21, and its comparison with metformin, on brain pathologies in HFD-induced prediabetes has never been investigated.

EXPERIMENTAL APPROACH: Male Wistar rats were given either a normal diet (ND) (n = 8) or a HFD (n = 104) for 16 weeks. At the 13th week, ND-fed rats were given a vehicle, whereas HFD-fed rats were randomly divided into 13 subgroups. Each subgroup was given vehicle, L6H21 (three doses) or metformin (300-mg·kg-1 ·day-1 ) for 1, 2 or 4 weeks. Metabolic parameters, cognitive function, brain mitochondrial function, brain TLR4-MD-2 signalling, microglial morphology, brain oxidative stress, brain cell death and dendritic spine density were investigated.

KEY

RESULTS

HFD-fed rats developed prediabetes, neuroinflammation, brain pathologies and cognitive impairment. All doses of L6H21 and metformin given to HFD-fed rats at 2 and 4 weeks attenuated metabolic disturbance.

CONCLUSION AND IMPLICATIONS: In rats, L6H21 and metformin restored cognition and attenuated brain pathologies dose and time-dependently. These results indicate a neuroprotective role of MD-2 inhibitor in a model of prediabetes.

Для цитирования: Oo Thura Tun, Sumneang Natticha, Ongnok Benjamin, Arunsak Busarin, Chunchai Titikorn, Kerdphoo Sasiwan, Apaijai Nattayaporn, Pratchayasakul Wasana, Liang Guang, Chattipakorn Nipon, Chattipakorn Siriporn C. L6H21 protects against cognitive impairment and brain pathologies via toll-like receptor 4-myeloid differentiation factor 2 signalling in prediabetic rats.. British journal of pharmacology. 2021. DOI: 10.1111/bph.15741.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.